Intera Atlas
Run match
Sites / Tekton Research
Is this you?

Request access for Tekton Research with your @tektonresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Tekton Research

Unclaimed profile

Site Network · Austin, TX (4534 West Gate Blvd, Suite 110) · ~25+ sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.43Recruit soph 0.57
Quality Scorecard (1–100)
Overall74Recruit83Ops73Sponsor71Ther68

Performance (observed)

Historical trials
260
Completed
161
Terminated/Withdrawn
29
Completion rate
85%
Active now
68
Phase 2
104
Phase 3
151
Realized enrollment
757,480
First study year
2009
Years active
17
Match confidence
high
Enrollment velocity (inf)
44,558

Therapeutic

Areas
Cardiometabolic (Type 1/2 diabetes, obesity, MASH/MASLD, thyroid, endocrinology), CNS/neurology, psychiatry, general medicine
Specialties
Neurology & Psychiatry, Cardiometabolic (endocrine, diabetes, obesity), Vaccines & Infectious Disease, General Medicine, Pediatrics
Breadth (conditions)
197
Languages
English + Spanish (detected)
States
9 states

Recruitment (web observed)

Google Ads
Yes
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong clinical research content on neuroscience and cardiometabolic
Capability notes
Strong; centralized operations; experienced investigators; dedicated patient communities; rapid enrollment focus

Relationships

Sponsors
Pfizer; ModernaTX, Inc.; Eli Lilly and Company; AbbVie; BioNTech SE; Janssen Vaccines & Prevention B.V.
CROs
ICON plc; IQVIA Pty Ltd; Parexel; Rho Federal Systems Division, Inc.
Partnerships
Todata Analytics (SiteGrades/Tod AI platform, Nov 2025)
Owner / parent
Private; co-founded by Kip McKenzie (founder, board member)
Expansion
Y (7 new sites 2025, San Antonio research hub opened April 2026, 4 new sites in first half 2025)
Recent hiring
Y (Continuous expansion, 7 new sites added 2025)

Capacity & people

Investigators
—
Coordinators
—
CEO
Corey Collins
VP Clinical Ops
Taryn Collett (Chief Operating Officer)
VP Site Ops
Taryn Collett (COO oversees site operations)
VP Recruitment
Unknown
Emails
info@tektonresearch.com; (855) 380-2822; (512) 388-5717

Tech & DCT

eConsent
Yes
Builds tech
Vendors (IGNITE Network)
DCT / decentralized
Y (25+ sites across 9 states, North America)
Tech stack
Allucent's IGNITE Site Network platform; technology harmonization and integration
Recruiting visible
Y

Notes

25+ sites across 9 states with cardiometabolic specialization; physician-led model; part of Allucent's IGNITE pre-qualified network; strong enrollment focus and rapid startup. Excellent Intera fit—multiple sites, cardiometabolic/endocrinology focus (high-enrollment therapeutic area), recruitment-constrained growth model, centralized operations, demonstrated enrollment capability. Technology-forward approach. [Validated: 9 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.43Overall74

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.